Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
ENTA - TOTAL OTHER INCOME
Total Other Income ENTA - Enanta Pharmaceuticals, Inc.
3.9 M
LAST VALUE
53.52%
2 YEAR CAGR
-15.04%
5 YEAR CAGR
30.01%
10 YEAR CAGR